Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2013
At a glance
- Drugs Pioglitazone (Primary) ; Vildagliptin (Primary)
- Indications Diabetes mellitus; Glucose intolerance
- Focus Therapeutic Use
- Acronyms GCPD
- 07 Jun 2017 Biomarkers information updated
- 13 Apr 2013 Planned number of patients changed from 48 to 114 as reported by European Clinical Trials Database record.
- 02 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History